BARR
Anyone still holding this one besides me?
biz.yahoo.com
Tuesday March 14, 7:15 am Eastern Time
Company Press Release
Barringer Technologies Develops a Bacteria Detection
Application for Its IONSCAN Trace Detector
- Preliminary Field Test Results to be Presented at Pittsburgh Conference on March 15, 2000 -
WARREN, N.J.--(BUSINESS WIRE)--March 14, 2000-- Barringer Technologies Inc. (NASDAQ: BARR - news), the
world's leading developer, manufacturer and marketer of drug and explosive trace detection equipment, announced today that it
has developed a bacteria detection application for its IONSCAN (R) detector working collaboratively with the University of
Connecticut. A presentation of this capability, and preliminary field test results, will be presented on March 15, 2000 to the
Pittsburgh Conference, the world's largest analytical instrumentation conference.
Mr. J. Richard Jadamec, Co-Director Coastal Environmental Laboratories at the University of Connecticut, commented, ``The
detection algorithms we have developed provide specific detection and identification of a variety of bacterial species, such as
Listeria, E. coli, and Serratia marcescens which are typically found in pathogenic contaminants in food and water. We are now
field testing the IONSCAN's (R) Listeria detection capabilities, running side by side tests with other commercial techniques.
Results to date have been extraordinary in terms of identifying and differentiating the pathogenic Listeria monocytogenes from
other species of Listeria. Once fully developed, the IONSCAN (R) is expected to offer shorter response times than existing
techniques and much lower costs per sample for a wide variety of bacterial detection applications.'
Mr. Kenneth Wood, President and Chief Operating Officer of Barringer Technologies, further noted, ``Our joint effort with the
University of Connecticut began last year pursuant to our strategic growth plan to develop new market opportunities for our
core technology in the life sciences field. We're very excited about the results obtained to date and the potential of using the
IONSCAN (R) to provide quicker and significantly less expensive detection and identification capability for a number of
bacterial applications. We believe that there are significant market opportunities in food, clinical, and environmental
microbiological testing laboratories for the detection and identification of bacterial pathogens. Further, we expect to explore the
possibility of extending this capability to the detection of biological warfare agents, which is one of the next major areas of focus
for military and civil defense agencies around the world.'
Mr. Wood continued ``We are presently assessing various marketing and sales distribution options including scientific product
distributors as well as in-house sales and marketing in anticipation of commercializing this capability late in the second half of
2000.' |
